Provident Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.95M | Hold |
14,000
| – | – | 0.19% | 30 |
|
|
2025
Q4 | $1.72M | Hold |
14,000
| – | – | 0.16% | 33 |
|
|
2025
Q3 | $1.55M | Hold |
14,000
| – | – | 0.14% | 30 |
|
|
2025
Q2 | $1.55M | Hold |
14,000
| – | – | 0.13% | 27 |
|
|
2025
Q1 | $1.57M | Hold |
14,000
| – | – | 0.15% | 29 |
|
|
2024
Q4 | $1.29M | Sell |
14,000
-927
| -6% | -$83.5K | 0.12% | 32 |
|
|
2024
Q3 | $1.25M | Buy |
14,927
+927
| +7% | +$70.7K | 0.11% | 33 |
|
|
2024
Q2 | $961K | Hold |
14,000
| – | – | 0.09% | 38 |
|
|
2024
Q1 | $1.03M | Hold |
14,000
| – | – | 0.09% | 35 |
|
|
2023
Q4 | $1.13M | Sell |
14,000
-1,338
| -9% | -$104K | 0.11% | 34 |
|
|
2023
Q3 | $1.15M | Hold |
15,338
| – | – | 0.13% | 29 |
|
|
2023
Q2 | $1.18M | Hold |
15,338
| – | – | 0.13% | 28 |
|
|
2023
Q1 | $1.27M | Hold |
15,338
| – | – | 0.14% | 29 |
|
|
2022
Q4 | $1.32M | Buy |
15,338
+1,338
| +10% | +$106K | 0.16% | 30 |
|
|
2022
Q3 | $864K | Hold |
14,000
| – | – | 0.11% | 35 |
|
|
2022
Q2 | $865K | Hold |
14,000
| – | – | 0.1% | 35 |
|
|
2022
Q1 | $832K | Sell |
14,000
-13,000
| -48% | -$831K | 0.08% | 39 |
|
|
2021
Q4 | $1.96M | Hold |
27,000
| – | – | 0.18% | 30 |
|
|
2021
Q3 | $1.89M | Hold |
27,000
| – | – | 0.18% | 29 |
|
|
2021
Q2 | $1.86M | Sell |
27,000
-10,400
| -28% | -$694K | 0.18% | 30 |
|
|
2021
Q1 | $2.42M | Sell |
37,400
-57,877
| -61% | -$3.73M | 0.27% | 26 |
|
|
2020
Q4 | $5.55M | Sell |
95,277
-409,878
| -81% | -$24.7M | 0.65% | 23 |
|
|
2020
Q3 | $31.9M | Buy |
505,155
+10,059
| +2% | +$698K | 4.35% | 13 |
|
|
2020
Q2 | $38.1M | Buy |
495,096
+127,488
| +35% | +$9.77M | 5.55% | 6 |
|
|
2020
Q1 | $27.5M | Sell |
367,608
-105,719
| -22% | -$7.3M | 5.12% | 9 |
|
|
2019
Q4 | $30.8M | Buy |
473,327
+1,044
| +0.2% | +$68K | 4.25% | 14 |
|
|
2019
Q3 | $29.9M | Buy |
472,283
+42,388
| +10% | +$2.77M | 4.49% | 12 |
|
|
2019
Q2 | $29M | Buy |
429,895
+49,518
| +13% | +$3.26M | 4.3% | 11 |
|
|
2019
Q1 | $24.7M | Buy |
380,377
+5,691
| +2% | +$378K | 4.06% | 13 |
|
|
2018
Q4 | $23.4M | Sell |
374,686
-27,601
| -7% | -$1.93M | 4.19% | 12 |
|
|
2018
Q3 | $31.1M | Sell |
402,287
-3,074
| -0.8% | -$232K | 4.42% | 11 |
|
|
2018
Q2 | $28.7M | Buy |
405,361
+15,707
| +4% | +$1.11M | 4.07% | 13 |
|
|
2018
Q1 | $29.4M | Buy |
389,654
+6,883
| +2% | +$547K | 4.64% | 11 |
|
|
2017
Q4 | $27.4M | Buy |
382,771
+1,713
| +0.4% | +$130K | 4.38% | 9 |
|
|
2017
Q3 | $30.9M | Buy |
381,058
+4,327
| +1% | +$331K | 5.23% | 4 |
|
|
2017
Q2 | $26.7M | Buy |
376,731
+12,682
| +3% | +$844K | 4.85% | 8 |
|
|
2017
Q1 | $24.7M | Buy |
364,049
+19,961
| +6% | +$1.4M | 4.6% | 11 |
|
|
2016
Q4 | $24.6M | Buy |
344,088
+14,334
| +4% | +$1.07M | 4.78% | 10 |
|
|
2016
Q3 | $26.1M | Buy |
329,754
+3,441
| +1% | +$280K | 5.42% | 3 |
|
|
2016
Q2 | $27.2M | Sell |
326,313
-11,780
| -3% | -$1.05M | 5.61% | 2 |
|
|
2016
Q1 | $31.1M | Buy |
338,093
+5,100
| +2% | +$460K | 6.21% | 2 |
|
|
2015
Q4 | $33.7M | Buy |
332,993
+339
| +0.1% | +$35.3K | 6.78% | 2 |
|
|
2015
Q3 | $32.7M | Sell |
332,654
-3,575
| -1% | -$397K | 6.84% | 2 |
|
|
2015
Q2 | $39.4M | Buy |
336,229
+1,915
| +0.6% | +$209K | 7.8% | 1 |
|
|
2015
Q1 | $32.8M | Sell |
334,314
-10,343
| -3% | -$1.05M | 6.67% | 2 |
|
|
2014
Q4 | $32.5M | Sell |
344,657
-30,610
| -8% | -$3.17M | 7.08% | 2 |
|
|
2014
Q3 | $39.9M | Sell |
375,267
-817
| -0.2% | -$80K | 9.31% | 1 |
|
|
2014
Q2 | $31.2M | Buy |
376,084
+20,435
| +6% | +$1.59M | 7.36% | 2 |
|
|
2014
Q1 | $25.2M | Sell |
355,649
-10,370
| -3% | -$813K | 6.25% | 2 |
|
|
2013
Q4 | $27.5M | Sell |
366,019
-21,625
| -6% | -$1.51M | 6.97% | 2 |
|
|
2013
Q3 | $24.4M | Sell |
387,644
-16,337
| -4% | -$976K | 6.64% | 2 |
|
|
2013
Q2 | $20.7M | Buy |
+403,981
| New | +$21.1M | 6.16% | 2 |
|
Other funds holding GILD
VCM
VPM
Provident Investment Management's GILD Position: Q1 2026 in Review
Provident Investment Management held its Gilead Sciences (GILD) position steady in Q1 2026 at 14,000 shares worth $1.95M. The position accounts for 0.19% of the portfolio, ranked #30.
Provident Investment Management first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $39.9M in Q3 2014. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Provident Investment Management held 14,000 shares of Gilead Sciences worth $1.95M as of Q1 2026.
- Provident Investment Management left its Gilead Sciences share count unchanged in Q1 2026.
- Gilead Sciences made up 0.19% of Provident Investment Management's portfolio in Q1 2026, its #30 holding.
- Provident Investment Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Provident Investment Management's Gilead Sciences position peaked at $39.9M in Q3 2014.
- 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Provident Investment Management's 13F filing for Q1 2026, filed 13 May 2026.